RNA-Seq Blog Transcriptome Research & Industry News
A study of more than 23,000 samples carried out by teams across the UK shows Oxford Nanopore’s COVID-19 test, LamPORE, is highly accurate for...
Read More »Large study in UK NHS labs shows gold-standard accuracy of Oxford Nanopore’s COVID-19 test
Search Results for: COVID-19
Ginkgo Bioworks and Octant partner to expand COVID-19 testing capacity using next-generation sequencing technology
Partnership will bring large-scale test processing capacity to the San Francisco Bay Area as part of Ginkgo’s plans to expand testing nationwide Today, Ginkgo Bioworks, and Octant announced a...
Read More »Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening
Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced today the launch of a pioneering ultra-high-throughput SARS-CoV-2 test that will allow for the first time a true mass screening of the whole population. This test allows ...
Read More »RNA Sequencing data suggests that COVID-19 patients’ deaths may be due to uncontrolled host inflammatory processes rather than an active viral infection
Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, has resulted thus far in greater than 933,000 deaths worldwide; yet...
Read More »UCLA Health scientists pioneer faster and cheaper COVID-19 testing technology
The U.S. Food and Drug Administration has granted emergency use authorization for scientists at UCLA Health to begin using a new method of COVID-19 detection using sequencing technology called SwabSeq. The method is capable of testing thousands of...
Read More »RNA-seq reveals why every COVID-19 case is different
As scientists around the world develop life-saving COVID-19 vaccines and therapies, many are still wondering exactly why the disease proves deadly in some people and mild in others. To solve this puzzle, scientists need an in-depth understanding of how the ...
Read More »Single cell transcriptome analysis reveals biomarker that predicts who will have severe COVID-19
Airway cell analyses showing an activated immune axis could pinpoint the COVID-19 patients who will most benefit from targeted therapies. KAIST researchers have identified key markers that could help pinpoint patients who are bound to get a severe...
Read More »BeiGene and Singlomics sign license agreement for neutralizing COVID-19 antibodies identifed with scRNA-Seq
BeiGene, Ltd. and Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd., today announced that the companies have executed an exclusive license agreement for BeiGene to develop, manufacture and...
Read More »RNA sequencing project will help predict COVID-19 disease severity, inform treatment decisions
As part of Emory University’s participation in the multi-center Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC), the Yerkes National Primate Research Center has received a one-year, $4.1 million grant supplement from the National...
Read More »Multi-omic data and interactive web tool made publicly available to aid COVID-19 research
Why is it that some COVID-19 patients become extremely ill and die, while others experience only mild symptoms? The molecular underpinnings of...
Read More »